Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Slomovitz

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|August 7, 2004
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 casesPamela T Soliman, Brian M Slomovitz, Russell R Broaddus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Study outcome and journal impact factor: a meta-epidemiologic analysis of phase III gynecologic oncology trialsGabriel Levin, Emily Eiley, Lucy Gilbert, et al.
Gynecologic Oncology|September 21, 2020
mRNA expression in low grade serous ovarian cancer: Results of a nanoString assay in a diverse populationScott E Jordan, Heba Saad, Alex Sanchez Covarrubias, et al.
The American Journal of Surgical Pathology|April 30, 2002
A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary componentBrian M Slomovitz, Thomas A Caputo, Herbert F Gretz, et al.
American Journal of Obstetrics and Gynecology|September 5, 2009
Intravenous leiomyomatosis with intracardiac extension: a single-institution experienceMicheal J Worley, Anate Aelion, Thomas A Caputo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 10, 2020
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancerAnca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, et al.
Gynecologic Oncology|September 24, 2004
Expression of imatinib mesylate-targeted kinases in endometrial carcinomaBrian M Slomovitz, Russell R Broaddus, Rosemarie Schmandt, et al.
Gynecologic Oncology|March 6, 2015
Incidental power morcellation of malignancy: a retrospective cohort studyKerry Graebe, Arlene Garcia-Soto, Michael Aziz, et al.
Gynecologic Oncology|May 7, 2020
COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapiesBradley J Monk, Robert L Coleman, Kathleen N Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Her-2/neu overexpression and amplification in uterine papillary serous carcinomaBrian M Slomovitz, Russell R Broaddus, Thomas W Burke, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|August 7, 2004
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 casesPamela T Soliman, Brian M Slomovitz, Russell R Broaddus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2026
Study outcome and journal impact factor: a meta-epidemiologic analysis of phase III gynecologic oncology trialsGabriel Levin, Emily Eiley, Lucy Gilbert, et al.
Gynecologic Oncology|September 21, 2020
mRNA expression in low grade serous ovarian cancer: Results of a nanoString assay in a diverse populationScott E Jordan, Heba Saad, Alex Sanchez Covarrubias, et al.
The American Journal of Surgical Pathology|April 30, 2002
A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary componentBrian M Slomovitz, Thomas A Caputo, Herbert F Gretz, et al.
American Journal of Obstetrics and Gynecology|September 5, 2009
Intravenous leiomyomatosis with intracardiac extension: a single-institution experienceMicheal J Worley, Anate Aelion, Thomas A Caputo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 10, 2020
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancerAnca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, et al.
Gynecologic Oncology|September 24, 2004
Expression of imatinib mesylate-targeted kinases in endometrial carcinomaBrian M Slomovitz, Russell R Broaddus, Rosemarie Schmandt, et al.
Gynecologic Oncology|March 6, 2015
Incidental power morcellation of malignancy: a retrospective cohort studyKerry Graebe, Arlene Garcia-Soto, Michael Aziz, et al.
Gynecologic Oncology|May 7, 2020
COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapiesBradley J Monk, Robert L Coleman, Kathleen N Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Her-2/neu overexpression and amplification in uterine papillary serous carcinomaBrian M Slomovitz, Russell R Broaddus, Thomas W Burke, et al.
Pageof 11